Impact of beta-blocker use on the long-term outcomes of heart failure patients with chronic obstructive pulmonary disease.

ABSTRACT:

Aims

The number of patients with both chronic obstructive pulmonary disease (COPD) and heart failure (HF) is increasing in Asia, and these conditions often coexist. We previously revealed a tendency of beta-blocker underuse among patients with HF with reduced ejection fraction (HFrEF) and COPD in Asian countries other than Japan. Here, we evaluated the impact of cardio-selective beta-blocker use on the long-term outcomes of patients with HF and COPD.

Methods and results

Among the 5232 patients with HFrEF (left ventricular ejection fraction of <40%) prospectively enrolled from 11 Asian regions in the ASIAN-HF registry, 412 (7.9%) had a history of COPD. We compared the clinical characteristics and long-term outcomes of the patients with HF and COPD according to the use and typ

SUBMITTER: Kubota Y 

PROVIDER: S-EPMC8497364 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature